S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   191.69 (-0.96%)
AAPL   236.41 (+0.48%)
FB   185.85 (-2.38%)
MSFT   137.41 (-1.63%)
AMZN   1,757.51 (-1.68%)
NVDA   190.49 (-1.96%)
AMD   30.97 (-0.55%)
T   38.47 (+1.75%)
F   9.29 (+1.98%)
GILD   64.91 (-0.49%)
S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   191.69 (-0.96%)
AAPL   236.41 (+0.48%)
FB   185.85 (-2.38%)
MSFT   137.41 (-1.63%)
AMZN   1,757.51 (-1.68%)
NVDA   190.49 (-1.96%)
AMD   30.97 (-0.55%)
T   38.47 (+1.75%)
F   9.29 (+1.98%)
GILD   64.91 (-0.49%)
Log in

Krystal Biotech News Headlines (NASDAQ:KRYS)

$36.07
-1.68 (-4.45 %)
(As of 10/18/2019 04:00 PM ET)
Today's Range
$35.20
Now: $36.07
$38.22
50-Day Range
$32.88
MA: $41.41
$48.98
52-Week Range
$16.82
Now: $36.07
$51.67
Volume107,741 shs
Average Volume206,787 shs
Market Capitalization$624.01 million
P/E RatioN/A
Dividend YieldN/A
Beta1

Headlines

Krystal Biotech (NASDAQ KRYS) News Headlines

Source:
DateHeadline
Krystal Biotech Inc (NASDAQ:KRYS) Receives Consensus Rating of "Buy" from AnalystsKrystal Biotech Inc (NASDAQ:KRYS) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - October 15 at 1:36 AM
Krystal Biotech Inc (NASDAQ:KRYS) Sees Significant Growth in Short InterestKrystal Biotech Inc (NASDAQ:KRYS) Sees Significant Growth in Short Interest
www.americanbankingnews.com - October 12 at 7:47 PM
BRIEF-Krystal Biotech Receives Positive EMA Opinion On Orphan Designation For KB105BRIEF-Krystal Biotech Receives Positive EMA Opinion On Orphan Designation For KB105
www.msn.com - October 11 at 2:58 AM
Krystal Biotech Receives Positive EMA Opinion on Orphan Designation for KB105 to Treat Patients With TGM1 Deficient Autosomal Recessive Congenital IchthyosisKrystal Biotech Receives Positive EMA Opinion on Orphan Designation for KB105 to Treat Patients With TGM1 Deficient Autosomal Recessive Congenital Ichthyosis
finance.yahoo.com - October 10 at 9:04 AM
Before You Buy Krystal Biotech, Inc. (NASDAQ:KRYS), Consider Its VolatilityBefore You Buy Krystal Biotech, Inc. (NASDAQ:KRYS), Consider Its Volatility
finance.yahoo.com - October 4 at 4:00 PM
Krystal Biotech Inc (NASDAQ:KRYS) Expected to Announce Earnings of -$0.39 Per ShareKrystal Biotech Inc (NASDAQ:KRYS) Expected to Announce Earnings of -$0.39 Per Share
www.americanbankingnews.com - October 2 at 3:15 PM
Krystal Biotech (NASDAQ:KRYS) PT Set at $81.00 by GuggenheimKrystal Biotech (NASDAQ:KRYS) PT Set at $81.00 by Guggenheim
www.americanbankingnews.com - September 30 at 8:06 PM
Krystal Biotech to Present at the Cantor 2019 Global Healthcare Conference and Chardans 3rd Annual Genetic Medicines ConferenceKrystal Biotech to Present at the Cantor 2019 Global Healthcare Conference and Chardan's 3rd Annual Genetic Medicines Conference
finance.yahoo.com - September 30 at 8:23 AM
Krystal Biotech Announces Granting of its First Foreign Patent and Reinforces its IP Portfolio with a New U.S. PatentKrystal Biotech Announces Granting of its First Foreign Patent and Reinforces its IP Portfolio with a New U.S. Patent
finance.yahoo.com - September 27 at 5:23 PM
Krystal Biotech (NASDAQ:KRYS) Earns Neutral Rating from Analysts at Goldman Sachs GroupKrystal Biotech (NASDAQ:KRYS) Earns Neutral Rating from Analysts at Goldman Sachs Group
www.americanbankingnews.com - September 24 at 8:39 AM
Krystal Biotech: KB-103 Sprints To Become The First Approved Topical Gene Therapy For Skin DiseaseKrystal Biotech: KB-103 Sprints To Become The First Approved Topical Gene Therapy For Skin Disease
seekingalpha.com - September 19 at 11:40 PM
Krystal Biotech initiates early-stage study of gene therapy for rare skin disorderKrystal Biotech initiates early-stage study of gene therapy for rare skin disorder
seekingalpha.com - September 4 at 12:05 PM
Krystal Biotech Announces Initiation of Phase 1/2 Study of KB105 in Transglutaminase-1 (“TGM1”) Deficient Autosomal Recessive Congenital Ichthyosis (“ARCI”)Krystal Biotech Announces Initiation of Phase 1/2 Study of KB105 in Transglutaminase-1 (“TGM1”) Deficient Autosomal Recessive Congenital Ichthyosis (“ARCI”)
finance.yahoo.com - September 4 at 12:05 PM
Krystal Biotech Announces Attendance at Citi’s 14th Annual Biotech ConferenceKrystal Biotech Announces Attendance at Citi’s 14th Annual Biotech Conference
finance.yahoo.com - August 27 at 6:03 PM
Have Insiders Been Buying Krystal Biotech, Inc. (NASDAQ:KRYS) Shares?Have Insiders Been Buying Krystal Biotech, Inc. (NASDAQ:KRYS) Shares?
finance.yahoo.com - August 14 at 6:01 PM
Krystal Biotech EPS misses by $0.05Krystal Biotech EPS misses by $0.05
seekingalpha.com - August 5 at 9:31 AM
Krystal Biotech Reports Second Quarter 2019 Financial and Operating ResultsKrystal Biotech Reports Second Quarter 2019 Financial and Operating Results
finance.yahoo.com - August 5 at 9:31 AM
Krystal Biotech, Inc. Added to the Russell 2000 IndexKrystal Biotech, Inc. Added to the Russell 2000 Index
finance.yahoo.com - July 1 at 9:42 AM
Hedge Funds Have Never Been This Bullish On Krystal Biotech, Inc. (KRYS)Hedge Funds Have Never Been This Bullish On Krystal Biotech, Inc. (KRYS)
finance.yahoo.com - June 27 at 5:22 PM
Whitney IjemWhitney Ijem
www.benzinga.com - June 26 at 9:55 AM
Krystal Biotech Analyst Lifts Price Target More Than 50% On Positive Phase 2 Data, RMAT DesignationKrystal Biotech Analyst Lifts Price Target More Than 50% On Positive Phase 2 Data, RMAT Designation
finance.yahoo.com - June 25 at 5:52 PM
Krystal Biotech Rallies On Positive Trial Results For Skin ConditionKrystal Biotech Rallies On Positive Trial Results For Skin Condition
www.benzinga.com - June 25 at 10:02 AM
Krystal Biotech up 27% on positive KB103 data in rare skin disorderKrystal Biotech up 27% on positive KB103 data in rare skin disorder
seekingalpha.com - June 24 at 5:38 PM
Krystal Biotech shares up 27% after companys skin drug receives expedited review designation from FDAKrystal Biotech shares up 27% after company's skin drug receives expedited review designation from FDA
www.marketwatch.com - June 24 at 5:38 PM
Krystal Biotech Announces Proposed $100 Million Public Offering of Common StockKrystal Biotech Announces Proposed $100 Million Public Offering of Common Stock
www.nasdaq.com - June 24 at 5:38 PM
Krystal Biotech stock jumps after positive clinical trial resultsKrystal Biotech stock jumps after positive clinical trial results
www.bizjournals.com - June 24 at 5:38 PM
Krystal Submits Investigational New Drug (IND) Application for KB105, Topical Gene Therapy Candidate for Transglutaminase-1 Deficient Autosomal Recessive Congenital IchthyosisKrystal Submits Investigational New Drug (IND) Application for KB105, Topical Gene Therapy Candidate for Transglutaminase-1 Deficient Autosomal Recessive Congenital Ichthyosis
finance.yahoo.com - June 14 at 11:33 AM
Krystal Biotech (KRYS) Presents At RBC Capital Markets 2019 Healthcare Conference - SlideshowKrystal Biotech (KRYS) Presents At RBC Capital Markets 2019 Healthcare Conference - Slideshow
seekingalpha.com - May 23 at 6:08 PM
Krystal Biotech to Present at the RBC Capital Markets 2019 Healthcare ConferenceKrystal Biotech to Present at the RBC Capital Markets 2019 Healthcare Conference
finance.yahoo.com - May 15 at 9:44 AM
Krystal Biotech Reports First Quarter 2019 Financial Results and Provides Corporate UpdateKrystal Biotech Reports First Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - May 6 at 9:45 AM
Biotech News Recap: Upcoming Presentations For Krystal Biotech At SIDBiotech News Recap: Upcoming Presentations For Krystal Biotech At SID
seekingalpha.com - April 30 at 9:36 AM
Krystal Biotech Announces Five Presentations of Clinical and Preclinical Data at the Society for Investigative Dermatology Annual MeetingKrystal Biotech Announces Five Presentations of Clinical and Preclinical Data at the Society for Investigative Dermatology Annual Meeting
finance.yahoo.com - April 29 at 9:34 AM
Krystal Biotech: Game-Changing Gene Therapies For Serious Skin DiseasesKrystal Biotech: Game-Changing Gene Therapies For Serious Skin Diseases
seekingalpha.com - March 29 at 6:03 PM
EMA Grants PRIME Eligibility for KB103 to Treat Dystrophic Epidermolysis BullosaEMA Grants PRIME Eligibility for KB103 to Treat Dystrophic Epidermolysis Bullosa
finance.yahoo.com - March 29 at 9:55 AM
Krystal Biotech, Inc. Estimate MomentumKrystal Biotech, Inc. Estimate Momentum
www.nasdaq.com - March 21 at 5:18 AM
Krystal Biotech Reports 2018 Financial Results and Business ProgressKrystal Biotech Reports 2018 Financial Results and Business Progress
finance.yahoo.com - March 12 at 11:05 AM
Krystal (KRYS) in Focus: Stock Moves 5.1% HigherKrystal (KRYS) in Focus: Stock Moves 5.1% Higher
finance.yahoo.com - March 7 at 10:30 AM
Krystal Biotech christens new manufacturing facility for KB103Krystal Biotech christens new manufacturing facility for KB103
seekingalpha.com - March 6 at 6:09 PM
Krystal Biotech Continues Vertical Integration with Official Inauguration of Ancoris Gene Therapy Manufacturing Facility at its Pittsburgh HeadquartersKrystal Biotech Continues Vertical Integration with Official Inauguration of Ancoris Gene Therapy Manufacturing Facility at its Pittsburgh Headquarters
finance.yahoo.com - March 6 at 9:58 AM
Pharma manufacturing center opens in South Side; more jobs lannedPharma manufacturing center opens in South Side; more jobs lanned
www.msn.com - March 5 at 5:39 PM
Krystal Strengthens Board of Directors with Appointment of Julian S. GangolliKrystal Strengthens Board of Directors with Appointment of Julian S. Gangolli
finance.yahoo.com - March 4 at 10:18 AM
Krystal Biotech to Present at the Cowen and Company 39th Annual Health Care ConferenceKrystal Biotech to Present at the Cowen and Company 39th Annual Health Care Conference
finance.yahoo.com - March 1 at 10:08 AM
Krystal Biotech to Present at the 8th Annual SVB Leerink Global Healthcare Conference - NasdaqKrystal Biotech to Present at the 8th Annual SVB Leerink Global Healthcare Conference - Nasdaq
www.nasdaq.com - February 23 at 9:34 AM
Krystal Biotech: Institutional Ownership Is SwellingKrystal Biotech: Institutional Ownership Is Swelling
seekingalpha.com - February 22 at 10:54 AM
Krystal Biotech to Present at the 8th Annual SVB Leerink Global Healthcare ConferenceKrystal Biotech to Present at the 8th Annual SVB Leerink Global Healthcare Conference
finance.yahoo.com - February 22 at 10:54 AM
Krystal Biotech: Forget Botox, Is Gene Therapy The Answer To A Youthful Appearance?Krystal Biotech: Forget Botox, Is Gene Therapy The Answer To A Youthful Appearance?
seekingalpha.com - January 23 at 5:20 PM
Danforth Advisors entering Pittsburgh, focusing on life sciences sectorDanforth Advisors entering Pittsburgh, focusing on life sciences sector
finance.yahoo.com - January 18 at 8:00 PM
Local gene therapy company opens in-house manufacturing facilityLocal gene therapy company opens in-house manufacturing facility
www.bizjournals.com - January 15 at 5:08 PM
Krystal Biotech Completes Construction of Ancoris - A New GMP Facility for Commercial Manufacturing of a Viral Vector-Based Gene Therapy to Treat Dystrophic Epidermolysis BullosaKrystal Biotech Completes Construction of Ancoris - A New GMP Facility for Commercial Manufacturing of a Viral Vector-Based Gene Therapy to Treat Dystrophic Epidermolysis Bullosa
finance.yahoo.com - January 15 at 9:34 AM
Krystal Biotech: Update On KB103 Phase I Patients And Implications For Phase IIKrystal Biotech: Update On KB103 Phase I Patients And Implications For Phase II
seekingalpha.com - December 31 at 4:24 PM
This page was last updated on 10/18/2019 by MarketBeat.com Staff

Featured Article: Most Active Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel